SCHEMBL24311359

SCHEMBL24311359

Cc1ccccc1-c1ncn(-c2ccccc2)c1C

nearest known ligand 0.49

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
HTT P42858 2/20 0.49
ALDH1A1 P00352 2/20 0.49
MITF O75030 1/20 0.49
LMNA P02545 1/20 0.49
SMN1; SMN2 Q16637 1/20 0.49
SRC P12931 3/20 0.43
EGFR P00533 1/20 0.43
CDK1 P06493 1/20 0.43
GAA P10253 1/20 0.43
FGFR1 P11362 5/20 0.42
DCTPP1 Q9H773 1/20 0.41
CYP17A1 P05093 1/20 0.38
ADORA2A P29274 1/20 0.38
CYP1A2 P05177 1/20 0.38
CYP2D6 P10635 1/20 0.38
HPGD P15428 1/20 0.38
HIF1A Q16665 1/20 0.38
HSD17B10 Q99714 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26563121 0.89 HTT (0.45) HTTALDH1A1MITFLMNASMN1; SMN2
SCHEMBL22510633 0.74 ALDH1A1 (0.63) HTTALDH1A1SRCFGFR1CYP1A2
SCHEMBL13656880 0.72 FGFR1 (0.53) HTTALDH1A1SRCFGFR1CYP1A2
SCHEMBL19353774 0.70 CYP3A4 (0.50) ALDH1A1SMN1; SMN2SRCEGFRCDK1
SCHEMBL17691571 0.68 HTT (0.56) HTTALDH1A1SRCFGFR1CYP17A1
SCHEMBL20057789 0.68 ALDH1A1 (0.49) HTTALDH1A1MITFLMNASMN1; SMN2
SCHEMBL15507102 0.67 GPR119 (0.53) HTTALDH1A1SMN1; SMN2FGFR1
SCHEMBL23402655 0.67 NPC1 (0.47) HTTALDH1A1LMNASMN1; SMN2GAA
SCHEMBL23400873 0.67 DCTPP1 (0.43) ALDH1A1LMNASMN1; SMN2GAADCTPP1
SCHEMBL17691570 0.67 FGFR1 (0.65) HTTALDH1A1SRCFGFR1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220069241-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES UNIVERSAL DISPLAY CORPORATION (US) 2022-03-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220069241-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES CHRM1, LBR, CNKSR1 HTT 4059/4885ALDH1A1 352/4885MITF 2850/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.